𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous and oral demethoxydaunorubicin (NSC 256?439) in the treatment of acute leukemia and lymphoma: A pilot study

✍ Scribed by Eridani, S. ;Slater, N. G. P. ;Singh, A. K. ;Pearson, T. C.

Publisher
Springer-Verlag
Year
1985
Weight
251 KB
Volume
50
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vincristine (NSC-67574), cytosine arabin
Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): A pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults
✍ Sartiano, George P. ;Pfrimmer, Wayne J. ;Turner, A. Robert πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 412 KB

Fifteen newly diagnosed unselected adult patients with acute nonlymphocytic leukemia were treated in a pilot study of the combination of vincristine, cytosine arabinoside, 6-thioguanine, and daunorubicin (VAT-D) for remission induction therapy. Eleven of fifteen (75%) achieved a remission bone marro

A pilot study of epirubicin and chloramb
A pilot study of epirubicin and chlorambucil in the treatment of chronic lymphocytic leukemia (CLL)
✍ Dr G. M. Smith; J. A. Child; D. W. Milligan; M. A. McEvoy; J. A. Murray πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 428 KB

In a pilot study of the combination of epirubicin and chlorambucil in the treatment of chronic lymphocytic leukemia (CLL), 10 patients with advanced or progressive disease were treated in four centres. Up to a total of 15 courses in individual patients were given. Toxicity was relatively mild with n